Janessa Marie Broussard
Primary Care · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 3
- 1 carrier
- Office
- 1
Offices
1 location
Plans that list them
3 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Janessa Marie Broussard’s office at (415) 581-1600 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
Medicaid work
$226,916 in 2024
Medicaid paid $226,916 for 2,201 billed services this clinician did in 2024, up to 62 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 552 | $190,551 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 194 | $26,644 |
| COMPREHENSIVE METABOLIC PANEL | 160 | $2,745 |
| TREPONEMA PALLIDUM | 105 | $2,494 |
| T cells; absolute CD4 count | 43 | $2,443 |
| Blood test, lipids (cholesterol and triglycerides) | 27 | $706 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 63 | $560 |
| Syphilis test, non-treponemal antibody; qualitative (eg, VDRL, RPR, ART) | 61 | $489 |
| Return visit (30+ min) | 401 | $152 |
| SYPHILIS TEST QUANTITATIVE | 14 | $131 |
| Short return visit (20+ min) | 70 | $0 |
| Service | 511 | $0 |
| 2024 | 2,201 | 12 | 62 | $226,916 |
| 2023 | 1,102 | 6 | 34 | $108,470 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 327 | $108,084 |
| Return visit (30+ min) | 404 | $386 |
| COMPREHENSIVE METABOLIC PANEL | 13 | $0 |
| Infectious agent detection by nucleic acid (DNA or RNA); HIV-1, quantification, includes reverse transcription when performed | 13 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 52 | $0 |
| Service | 293 | $0 |
Drugs they prescribed that Part D paid
$1,594,338
Pharmacies billed $1,594,338 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (46 of 1,847) in 2024. Above the middle of the specialty; the typical nurse practitioner clinician is at 0%.
1,261 generic and fewer than 11 brand-name prescriptions · $1,594,338 in drug cost · 40 antibiotic prescriptions to 11 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Biktarvy | 139 | $568,186 | $4,088 |
| Triumeq | 66 | $241,564 | $3,660 |
| Tivicay | 68 | $159,262 | $2,342 |
| Odefsey | 22 | $99,283 | $4,513 |
| Descovy | 38 | $84,577 | $2,226 |
See all 59 drugs
| Biktarvy | 139 | $568,186 | $4,088 |
| Triumeq | 66 | $241,564 | $3,660 |
| Tivicay | 68 | $159,262 | $2,342 |
| Odefsey | 22 | $99,283 | $4,513 |
| Descovy | 38 | $84,577 | $2,226 |
| Symtuza | 17 | $79,179 | $4,658 |
| Cabenuva | 13 | $63,635 | $4,895 |
| Dovato | 12 | $40,511 | $3,376 |
| Vivitrol | 15 | $22,639 | $1,509 |
| Jublia | 12 | $16,447 | $1,371 |
| Jardiance | 14 | $9,177 | $655 |
| Eliquis | 15 | $8,520 | $568 |
| Gemtesa | 12 | $5,284 | $440 |
| Spiriva Respimat | 11 | $5,131 | $466 |
| Atovaquone | 11 | $2,728 | $248 |
| Albuterol Sulfate Hfa | 34 | $1,450 | $43 |
| Eplerenone | 12 | $971 | $81 |
| Haloperidol Decanoate | 13 | $689 | $53 |
| Gabapentin | 46 | $628 | $14 |
| Levetiracetam | 12 | $515 | $43 |
| Acyclovir | 34 | $499 | $15 |
| Atorvastatin | 96 | $456 | $5 |
| Flunisolide | 13 | $450 | $35 |
| Hydroxyzine | 43 | $385 | $9 |
| Digoxin | 12 | $360 | $30 |
| Metoprolol | 19 | $345 | $18 |
| Tamsulosin | 51 | $332 | $7 |
| Naltrexone | 12 | $327 | $27 |
| Bupropion Xl | 16 | $316 | $20 |
| Diphenoxylate-Atropine | 12 | $312 | $26 |
| Ritonavir | 12 | $308 | $26 |
| Torsemide | 12 | $282 | $24 |
| Levothyroxine | 11 | $273 | $25 |
| Benazepril | 53 | $269 | $5 |
| Sulfamethoxazole-Trimethoprim | 31 | $250 | $8 |
| Ibuprofen | 36 | $192 | $5 |
| Metformin Hcl Er | 35 | $184 | $5 |
| Aripiprazole | 12 | $176 | $15 |
| Hydrocodone-Acetaminophen | 18 | $174 | $10 |
| Fluoxetine | 32 | $174 | $5 |
| Mirtazapine | 23 | $168 | $7 |
| Omeprazole | 16 | $164 | $10 |
| Amlodipine Besylate | 26 | $162 | $6 |
| Famotidine | 29 | $159 | $5 |
| Ketoconazole | 13 | $155 | $12 |
| Spironolactone | 12 | $134 | $11 |
| Fluticasone Propionate | 19 | $128 | $7 |
| Metformin | 12 | $121 | $10 |
| Loperamide | 11 | $117 | $11 |
| Triamcinolone Acetonide | 16 | $102 | $6 |
| Losartan | 23 | $90 | $4 |
| Benztropine Mesylate | 12 | $85 | $7 |
| Pantoprazole | 17 | $84 | $5 |
| Quetiapine | 19 | $82 | $4 |
| Escitalopram | 20 | $78 | $4 |
| Lamotrigine | 11 | $44 | $4 |
| Lisinopril | 23 | $37 | $2 |
| Oxycodone | 11 | $34 | $3 |
| Cyclobenzaprine | 16 | $34 | $2 |
Year by year
| 2024 | 1,847 | 75 | 3% (46) | None | $1,594,338 |
| 2023 | 845 | 48 | 3% (21) | None | $843,912 |
| 2019 | 38 | 14 | 0% (0) | None | $21,238 |
| 2018 | 243 | 64 | 0% (0) | 28% | $156,862 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 24 drugs
| Biktarvy | 62 | $278,916 | $4,499 |
| Triumeq | 25 | $108,027 | $4,321 |
| Odefsey | 24 | $88,467 | $3,686 |
| Cabenuva | 13 | $76,583 | $5,891 |
| Tivicay | 27 | $62,710 | $2,323 |
| Descovy | 11 | $21,480 | $1,953 |
| Jublia | 11 | $17,720 | $1,611 |
| Eliquis | 11 | $6,350 | $577 |
| Atorvastatin | 50 | $1,001 | $20 |
| Acyclovir | 12 | $482 | $40 |
| Tamsulosin | 17 | $467 | $27 |
| Benazepril | 30 | $417 | $14 |
| Valacyclovir | 11 | $371 | $34 |
| Amlodipine Besylate | 18 | $305 | $17 |
| Sulfamethoxazole-Trimethoprim | 27 | $280 | $10 |
| Famotidine | 13 | $278 | $21 |
| Metformin Hcl Er | 22 | $272 | $12 |
| Escitalopram | 16 | $261 | $16 |
| Metformin | 15 | $253 | $17 |
| Lisinopril | 17 | $217 | $13 |
| Hydrocodone-Acetaminophen | 13 | $214 | $16 |
| Hydroxyzine | 21 | $210 | $10 |
| Ibuprofen | 15 | $203 | $14 |
| Fluoxetine | 11 | $168 | $15 |
2018: 3 drugs
| Biktarvy | 15 | $51,395 | $3,426 |
| Proair Hfa | 12 | $719 | $60 |
| Azithromycin | 16 | $104 | $7 |
Money from drug and device companies
$1,563 in 2021
A payment is not proof that care is biased.
| ViiV Healthcare | Dovato | $930 | 1 payment
|
| Gilead Sciences | None | $633 | 22 payments
|
See all 23 published payments
| Gilead Sciences | Meals · 2021-10-08 | None | $18 |
| Gilead Sciences | Meals · 2021-10-01 | None | $15 |
| Gilead Sciences | Meals · 2021-09-22 | None | $25 |
| Gilead Sciences | Meals · 2021-09-22 | None | $92 |
| ViiV Healthcare | Consulting · 2021-09-21 | Dovato | $930 |
| Gilead Sciences | Meals · 2021-09-01 | None | $29 |
| Gilead Sciences | Meals · 2021-08-19 | None | $32 |
| Gilead Sciences | Meals · 2021-07-16 | None | $18 |
| Gilead Sciences | Meals · 2021-06-24 | None | $26 |
| Gilead Sciences | Meals · 2021-06-17 | None | $15 |
| Gilead Sciences | Meals · 2021-06-04 | None | $27 |
| Gilead Sciences | Meals · 2021-05-19 | None | $28 |
| Gilead Sciences | Meals · 2021-05-14 | None | $30 |
| Gilead Sciences | Meals · 2021-04-30 | None | $26 |
| Gilead Sciences | Meals · 2021-04-20 | None | $23 |
| Gilead Sciences | Meals · 2021-03-26 | None | $31 |
| Gilead Sciences | Meals · 2021-03-05 | None | $27 |
| Gilead Sciences | Meals · 2021-02-26 | None | $32 |
| Gilead Sciences | Meals · 2021-02-12 | None | $24 |
| Gilead Sciences | Meals · 2021-02-05 | None | $27 |
| Gilead Sciences | Meals · 2021-01-29 | None | $27 |
| Gilead Sciences | Meals · 2021-01-15 | None | $30 |
| Gilead Sciences | Meals · 2021-01-08 | None | $30 |
Professional record
- NPI
- 1285159871
- Licence
- CA 95007103
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 363LP2300X (363LP2300X)
- Mailing address
- 470 Castro St, San Francisco, CA, 94114
- NPI first listed
- 2017-08-04
- NPI last updated
- 2018-12-13
This is when the NPI record was last certified, not a medical board exam.